Uncaria rhynchophylla Ameliorates Cognitive Deficits Induced by D-galactose in Mice

Abstract

The stem with hooks of Uncaria rhynchophylla is a component herb of many traditional formulae for the treatment of neurodegenerative diseases. However, scientific evidence of the efficacy of Uncaria rhynchophylla in the treatment of Alzheimer's disease (AD) in animal models is lacking. Thus, in the present study, we investigated whether the 70 % aqueous ethanol extract of Uncaria rhynchophylla (EUR) could protect against D-galactose (D-gal)-induced cognitive deficits in mice. Mice were given a subcutaneous injection of D-gal (50 mg/kg) and orally administered EUR (100, 200, or 400 mg/kg) daily for 8 weeks. The effect of EUR on D-gal-induced cognitive deficits was evaluated by measuring behavioral and neurochemical parameters of AD and the antioxidant status of brain tissue. The results showed that EUR (200 or 400 mg/kg) significantly increased exploratory behavior (assessed by an open-field test) and improved spatial learning and memory function (assessed by the Morris water maze test) in D-gal-treated mice. In addition, EUR (200 or 400 mg/kg) significantly increased the levels of acetylcholine and glutathione and decreased the activity of acetylcholinesterase and the level of malondialdehyde in the brains of D-gal-treated mice. These results indicate that EUR ameliorates cognitive deficits induced by D-gal in mice, and that this action may be mediated, at least in part, by the inhibition of acetylcholinesterase activity and the enhancement of the antioxidant status of brain tissue.

Key words

Uncaria rhynchophylla (Miq.) Miq. ex Havil. - Rubiaceae - D-galactose - cognitive deficits - acetylcholinesterase - oxidative stress

References

• 1 Ivins K J, Ivins J K, Sharp J P, Cotman C W. Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by beta-amyloid.  J Biol Chem. 1999;  274 2107-2112
• 2 Wimo A, Winblad B, Aguero Torres H, von Strauss E. The magnitude of dementia occurrence in the world.  Alzheimer Dis Assoc Disord. 2003;  17 63-67
• 3 Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.  Int J Clin Pract Suppl. 2002;  127 45-63
• 4 Oken B S, Storzbach D M, Kaye J A. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.  Arch Neurol. 1998;  55 1409-1415
• 5 Kuramochi T, Chu J, Suga T. Gou-teng (from Uncaria rhynchophylla Miquel)-induced endothelium-dependent and -independent relaxations in the isolated rat aorta.  Life Sci. 1994;  54 2061-2065
• 6 Hsieh C L, Tang N Y, Chiang S Y, Hsieh C T, Lin J G. Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (MIQ) Jack and Gastrodia elata BI., in kainic acid-treated rats.  Life Sci. 1999;  65 2071-2082
• 7 Watanabe H, Zhao Q, Matsumoto K, Tohda M, Murakami Y, Zhang S H, Kang T H, Mahakunakorn P, Maruyama Y, Sakakibara I, Aimi N, Takayama H. Pharmacological evidence for antidementia effect of Choto-san (Gouteng-san), a traditional Kampo medicine.  Pharmacol Biochem Behav. 2003;  75 635-643
• 8 Tabuchi M, Yamaguchi T, Lizuka S, Imamura S, Ikarashi Y, Kase Y. Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease.  J Ethnopharmacol. 2009;  122 157-162
• 9 Kim D Y, Jung J A, Kim T H, Seo S W, Jung S K, Park C S. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-γ down-regulation in NC/Nga mice.  J Ethnopharmacol. 2009;  122 567-572
• 10 Jung J W, Ahn N Y, Oh H R, Lee B K, Lee K J, Kim S Y, Cheong J H, Ryu J H. Anxiolytic effects of the aqueous extract of Uncaria rhynchophylla.  J Ethnopharmacol. 2006;  108 193-197
• 11 Shim J S, Kim H G, Ju M S, Choi J G, Jeong S Y, Oh M S. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.  J Ethnopharmacol. 2009;  126 361-365
• 12 Fujiwara H, Iwasaki K, Furukawa K, Seki S, He M, Maruyama M, Tomita N, Kudo Y, Higuchi M, Saido T C, Maeda S, Takashima A, Hara M, Ohizumi Y, Arai H. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins.  J Neurosci Res. 2006;  84 427-433
• 13 Hellström-Lindahl E, Viitanen M, Marutle A. Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease.  Neurochem Int. 2009;  55 243-252
• 14 Zhang C, Wang S Z, Zuo P P, Cui X. Protective effect of tetramethylpyrazine on learning and memory function in D-galactose lesioned mice.  Chin Med Sci J. 2004;  19 180-184
• 15 Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, Packer L, Liu J. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration and oxidative damage in mice: protective effects of R-alpha-lipoic acid.  J Neurosci Res. 2006;  83 1584-1590
• 16 Lu J, Zheng Y L, Luo L, Wu D M, Sun D X, Feng Y J. Quercetin reverses D-galactose induced neurotoxicity in mouse brain.  Behav Brain Res. 2006;  171 251-260
• 17 Lu J, Zheng Y L, Wu D M, Luo L, Sun D X, Shan Q. Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose.  Biochem Pharmacol. 2007;  74 1078-1090
• 18 Zhong S Z, Ge Q H, Qu R, Li Q, Ma S P. Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by D-galactose in ICR mice.  J Neurol Sci. 2009;  277 58-64
• 19 Zhang Q, Li X K, Cui X, Zuo P P. D-galactose injured neurogenesis in the hippocampus of adult mice.  Neurol Res. 2005;  27 552-556
• 20 Lu J, Wu D M, Hu B, Cheng W, Zheng Y L, Zhang Z F, Ye Q, Fan S H, Shan Q, Wang Y J. Chronic administration of troxerutin protects mouse brain against D-galactose-induced impairment of cholinergic system.  Neurobiol Learn Mem. 2010;  93 157-164
• 21 Mao Q Q, Ip S P, Ko K M, Tsai S H, Xian Y F, Che C T. Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant-like activity.  J Ethnopharmacol. 2009;  124 316-320
• 22 Ellman G L, Courtney K O, Andres V J, Feather-Stone R M. A new and rapid colorimetric determination of acetylcholinesterase activity.  Biochem Pharmacol. 1961;  7 88-95
• 23 Barry D G, Mary J S, Davis S H, Shujath M A, Sandi L S, George P, Robert S, Richard W S. APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology.  Neurobiol Aging. 1996;  17 153-171
• 24 Lei M, Su Y, Hua X, Ding J, Han Q, Hu G, Xiao M. Chronic systemic injection of D-galactose impairs the septohippocampal cholinergic system in rats.  Neuroreport. 2008;  19 1611-1615
• 25 Long J, Wang X, Gao H, Liu Z, Liu C, Miao M, Cui X, Packer L, Liu J. D-galactose toxicity in mice is associated with mitochondrial dysfunction: protecting effects of mitochondrial nutrient R-alpha-lipoic acid.  Biogerontology. 2007;  8 373-381
• 26 Luo D D, An S C, Zhang X. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress.  Brain Res Bull. 2008;  72 8-12
• 27 Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein J B, Pierce W M, Booze R, Markesbery W R, Butterfield D A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.  Free Radic Biol Med. 2002;  33 562-571
• 28 De Iuliis A, Grigoletto J, Recchia A, Giusti P, Arslan P. A proteomic approach in the study of an animal model of Parkinson's disease.  Clin Chim Acta. 2005;  357 202-209
• 29 Johnson F B, Sinclair D A, Guarente L. Molecular biology of aging.  Cell. 1999;  96 291-302
• 30 Muthuraju S, Maiti P, Solanki P, Sharma A K, Amitabh, Singh S B, Prasad D, Ilavazhagan G. Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.  Behav Brain Res. 2009;  203 1-14
• 31 Bartus R T, Dean 3rd R L, Beer B, Lippa A S. Cholinergic hypothesis of geriatric memory dysfunction.  Science. 1982;  217 408-414
• 32 Lipton S A, Kater S B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival.  Trends Neurosci. 1989;  12 265-270
• 33 Small D H. A non-classical action of acetylcholinesterase and acetylcholine in the regulation of neurite outgrowth.  J Neurochem. 1995;  65 (Suppl.) S126C